BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1346 related articles for article (PubMed ID: 31334927)

  • 1. Effective and Safe Repeated Full-Face Treatments With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin Boosting Hyaluronic Acid.
    Hedén P; Hexsel D; Cartier H; Bergentz P; Delmar H; Camozzato F; Siega C; Skoglund C; Edwartz C; Norberg M; Kestemont P
    J Drugs Dermatol; 2019 Jul; 18(7):682-689. PubMed ID: 31334927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler.
    Cartier H; Hedén P; Delmar H; Bergentz P; Skoglund C; Edwartz C; Norberg M; Kestemont P
    Dermatol Surg; 2020 Apr; 46(4):475-482. PubMed ID: 31592825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical skin therapies in subjects undergoing full facial rejuvenation.
    Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A
    J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of hyaluronic acid fillers formulated to maintain natural facial expression.
    Solish N; Bertucci V; Percec I; Wagner T; Nogueira A; Mashburn J
    J Cosmet Dermatol; 2019 Jun; 18(3):738-746. PubMed ID: 31033110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hand Rejuvenation With A Hyaluronic Acid-Based Dermal Filler: A 12-Month Clinical Follow-Up Case Series.
    Micheels P; Besse S; Sibon M; Elias B
    J Drugs Dermatol; 2021 Apr; 20(4):451-459. PubMed ID: 33852241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Patient Satisfaction of a Hyaluronic Acid Filler Producing Enduring Full-Facial Volume Restoration: An 18-Month Open Multicenter Study.
    Talarico S; Meski AP; Buratini L; Manela-Azulay M; Simpson H; Sidou F; Kerrouche N
    Dermatol Surg; 2015 Dec; 41(12):1361-9. PubMed ID: 26606436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA and Hyaluronic Acid in Facial Wrinkles and Folds: A Prospective, Open-Label Comparison.
    Cohen JL; Swift A; Solish N; Fagien S; Glaser DA
    Aesthet Surg J; 2019 Jan; 39(2):187-200. PubMed ID: 29762642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-center comparative efficacy and safety study of two different hyaluronic acid fillers for treatment of nasolabial folds in a Chinese population.
    Li D; Sun J; Wu S
    J Cosmet Dermatol; 2019 Jun; 18(3):755-761. PubMed ID: 31074161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Two Resilient Hyaluronic Acid Fillers in the Treatment of Moderate-to-Severe Nasolabial Folds: A 64-Week, Prospective, Multicenter, Controlled, Randomized, Double-Blinded, and Within-Subject Study.
    Monheit G; Kaufman-Janette J; Joseph JH; Shamban A; Dover JS; Smith S
    Dermatol Surg; 2020 Dec; 46(12):1521-1529. PubMed ID: 32217842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments.
    Dayan SH; Ho TT; Bacos JT; Gandhi ND; Kalbag A; Gutierrez-Borst S
    J Drugs Dermatol; 2018 Jan; 17(1):48-54. PubMed ID: 29320587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, Safety, and Subject Satisfaction After AbobotulinumtoxinA Treatment of Upper Facial Lines.
    Hexsel D; Cartier H; Hedén P; Delmar H; Bergentz P; Camozzato F; Siega C; Skoglund C; Edwartz C; Rees D; Kestemont P
    Dermatol Surg; 2018 Dec; 44(12):1555-1564. PubMed ID: 30204739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Effectiveness of Hyaluronic Acid Fillers With Lidocaine for Full-Face Treatment in Asian Patients.
    Huang SH; Tsai TF
    J Drugs Dermatol; 2020 Sep; 19(9):836-842. PubMed ID: 33026748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Flexible Hyaluronic Acid Fillers in Lip and Perioral Enhancement.
    Bertucci V; Nikolis A; Solish N; Lane V; Hicks J
    J Drugs Dermatol; 2021 Apr; 20(4):402-408. PubMed ID: 33852235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of a new monophasic hyaluronic acid filler with lidocaine 0.3% in the correction of nasolabial fold.
    Suh JH; Oh CT; Im SI; Lim JS; Kim BJ; Lee JH
    J Cosmet Dermatol; 2017 Sep; 16(3):327-332. PubMed ID: 28145073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips.
    Cartier H; Trevidic P; Rzany B; Sattler G; Kestemont P; Kerrouche N; Dhuin JC
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s17-26. PubMed ID: 22497040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of small and large gel-particle hyaluronic acid in the correction of perioral wrinkles.
    Brandt F; Bassichis B; Bassichis M; O'Connell C; Lin X
    J Drugs Dermatol; 2011 Sep; 10(9):982-7. PubMed ID: 22052266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of tear troughs and periorbital lines with a range of customized hyaluronic acid fillers.
    Rzany B; Cartier H; Kestermont P; Trevidic P; Sattler G; Kerrouche N; Dhuin JC
    J Drugs Dermatol; 2012 Jan; 11(1 Suppl):s27-34. PubMed ID: 22497041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and instrumental evaluation of a cross-linked hyaluronic acid filler dermal injection: effects on nasolabial folds skin biophysical parameters and augmentation from a single-dose, monocentric, open-label trial.
    Cameli N; Mariano M; Serio M; Berardesca E
    G Ital Dermatol Venereol; 2016 Oct; 151(5):507-14. PubMed ID: 27139014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.